Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
287
Appointments
163
Departures
21
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,399 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Genpact LTD | Michael Weiner | Chief Financial OfficerCFO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Health Catalyst, Inc. | Benjamin Albert | Chief Executive Officer, President, principal executive officer and principal operating officer and member of the BoardCEO | Departed | Sep 13, 2026 | SEC 8-K |
| Sep 8, 2026 | Health Catalyst, Inc. | Benjamin Albert | Chief Business OfficerChief Business Officer | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 8, 2026 | HOULIHAN LOKEY, INC. | Gillian B. Zucker | directordirector | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Christopher Bergstrom | President and Chief Executive OfficerCEO | Departed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Christopher Bergstrom | Executive ChairmanExecutive Chairman | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Brandon Lorey | Chief Executive OfficerCEO | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Kent Carstater | President of JMSB and Chief Operating Officer of John Marshall BankPresident | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Nicholas Smith | Chief Financial OfficerCFO | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Joseph Zmitrovich | President of John Marshall Bank and Chief Revenue Officer of JMSBPresident | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | KIORA PHARMACEUTICALS INC | Keith Lane | Executive Vice President, Head of Clinical Development and Regulatory AffairsExecutive Vice President, Head of Clinical Development and Regulatory Affairs | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Kura Oncology, Inc. | Jennifer Fulk | Chief Financial OfficerCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Laird Superfood, Inc. | Mark Johnson | Chief Financial OfficerCFO | Appointed | Oct 1, 2026 | SEC 8-K |
| Sep 8, 2026 | LASE Corp. | Timothy A. Peterman | Acting CFOCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | LIQTECH INTERNATIONAL INC | David Noerby Foss Kowalczyk | Chief Financial and Operating OfficerCFO | Departed | Nov 30, 2026 | SEC 8-K |
| Sep 8, 2026 | MARKEL GROUP INC. | Steven A. Markel | Chairman of the Board of DirectorsChairman of the Board of Directors | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | MARKEL GROUP INC. | Steven A. Markel | member of the Boardmember of the Board | Departed | n/a | SEC 8-K |
| Sep 8, 2026 | MARKEL GROUP INC. | Thomas S. Gayner | ChairmanChairman | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | MARKEL GROUP INC. | Simon Wilson | Co-President and Chief Executive Officer, Markel InsurancePresident | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | MARKEL GROUP INC. | Andrew G. Crowley | Co-President and Chief Executive Officer, Markel VenturesPresident | Appointed | Sep 8, 2026 | SEC 8-K |
- Genpact LTDDeparted
Michael Weiner CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Health Catalyst, Inc.Departed
Benjamin Albert CEO
Filed Sep 8, 2026Effective Sep 13, 2026SEC 8-K
- Health Catalyst, Inc.Appointed
Benjamin Albert Chief Business Officer
Filed Sep 8, 2026Effective Sep 14, 2026SEC 8-K
- HOULIHAN LOKEY, INC.Appointed
Gillian B. Zucker director
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Departed
Christopher Bergstrom CEO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Christopher Bergstrom Executive Chairman
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Brandon Lorey CEO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Kent Carstater President
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Nicholas Smith CFO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Joseph Zmitrovich President
Filed Sep 8, 2026SEC 8-K
- KIORA PHARMACEUTICALS INCAppointed
Keith Lane Executive Vice President, Head of Clinical Development and Regulatory Affairs
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Kura Oncology, Inc.Appointed
Jennifer Fulk CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Laird Superfood, Inc.Appointed
Mark Johnson CFO
Filed Sep 8, 2026Effective Oct 1, 2026SEC 8-K
- LASE Corp.Appointed
Timothy A. Peterman CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- LIQTECH INTERNATIONAL INCDeparted
David Noerby Foss Kowalczyk CFO
Filed Sep 8, 2026Effective Nov 30, 2026SEC 8-K
- MARKEL GROUP INC.Departed
Steven A. Markel Chairman of the Board of Directors
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- MARKEL GROUP INC.Departed
Steven A. Markel member of the Board
Filed Sep 8, 2026SEC 8-K
- MARKEL GROUP INC.Appointed
Thomas S. Gayner Chairman
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- MARKEL GROUP INC.Appointed
Simon Wilson President
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- MARKEL GROUP INC.Appointed
Andrew G. Crowley President
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K